IR Biosciences Holdings Inc. (IRBS)
IRBS Stock Price Chart
Explore IR Biosciences Holdings Inc. interactive price chart. Choose custom timeframes to analyze IRBS price movements and trends.
IRBS Company Profile
Discover essential business fundamentals and corporate details for IR Biosciences Holdings Inc. (IRBS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jun 2023
Employees
4.00
CEO
Chet Leach D.A.B.T.
Description
IR BioSciences Holdings, Inc. operates as a development stage biotechnology company in the United States. The company, through its subsidiary, ImmuneRegen BioSciences, Inc., engages in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia. It is involved in the development of Homspera, and its derivates Radilex and Viprovex, for human stem cell stimulation, immune system stimulation and anti-infective activity, vaccine adjuvancy, and wound healing. IR BioSciences Holdings, Inc. was founded in 1999 and is headquartered in Scottsdale, Arizona.
IRBS Financial Timeline
Browse a chronological timeline of IR Biosciences Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
IRBS Stock Performance
Access detailed IRBS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.